Kidialyte

Magnesium Chloride Hexahydrate, the active ingredient in Kidialyte, is an electrolyte solution presented as an intravenous solution for intravenous use. It restores plasma electrolyte concentrations and fluid balance in patients who require electrolyte replacement, such as those with hypokalemia, hypomagnesemia, hyponatremia, or calcium deficiency.

GNH USA supplies Kidialyte as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Kidialyte is an intravenous electrolyte solution used to correct deficits in key plasma electrolytes and support fluid balance. - Electrolyte replacement: restores normal plasma levels of magnesium, potassium, sodium, and calcium in patients with documented deficiencies. - Fluid resuscitation: provides isotonic fluid volume to support circulatory stability in dehydrated or shock patients. - Treatment of hypokalemia: supplies potassium to raise serum potassium concentrations safely. - Treatment of hypomagnesemia: delivers magnesium to correct low serum magnesium. - Treatment of hyponatremia: adds sodium chloride to raise serum sodium. - Treatment of calcium deficiency: supplies calcium chloride to normalize calcium levels.

Kidialyte may be associated with infusion‑related reactions and electrolyte disturbances.

Common Side Effects: - Infusion site pain or irritation: mild discomfort at the catheter site. - Transient hyperkalemia: slight rise in serum potassium. - Transient hypermagnesemia: mild increase in serum magnesium. - Nausea or vomiting: gastrointestinal upset during infusion. - Headache: mild cephalic discomfort. - Flushing or warmth: sensation of heat during administration.

Serious or Rare Side Effects: - Severe hyperkalemia: potentially life‑threatening cardiac arrhythmias. - Cardiac arrhythmia: abnormal heart rhythm due to electrolyte imbalance. - Anaphylactic reaction: rare severe allergic response. - Severe hypermagnesemia: muscle weakness, respiratory depression. - Hypotension: sudden drop in blood pressure during rapid infusion. - Metabolic acidosis: disturbance of acid‑base balance.

Kidialyte should be administered with careful clinical monitoring. - Baseline assessment: obtain serum electrolyte levels before initiation. - Cardiac monitoring: observe ECG for arrhythmias during infusion. - Renal impairment: adjust infusion rate and volume in patients with reduced kidney function. - Heart failure: avoid rapid large‑volume infusions that may exacerbate fluid overload. - Infusion rate: do not exceed recommended flow rates to prevent electrolyte spikes. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Kidialyte can interact with other medications that affect electrolyte balance or cardiac function.

Major Interactions (Avoid): - Potassium‑sparing diuretics: may cause dangerous hyperkalemia. - ACE inhibitors or ARBs: increase risk of elevated potassium levels. - Digitalis glycosides: heightened risk of cardiac toxicity with electrolyte shifts.

Moderate Interactions (Monitor Closely): - Loop diuretics: may require adjustment of infusion composition. - NSAIDs: can affect renal handling of electrolytes. - Calcium channel blockers: monitor for additive effects on calcium levels.